The Canadian COVID‑19 Funded Research Database

Algonquin College
Ambrose University
Association for Canadian Studies
Athabasca University
Aurora College

B.C. Centre for Disease Control
B.C. Centre for Excellence in HIV/AIDS
B.C. Children's Hospital
B.C. Women's Hospital
Bishop's University
Brandon University
British Columbia Centre on Substance Use
Brock University
Bruyère Research Institute

Dalhousie University
Dawson College
Durham College

École de technologie supérieure
École nationale d'administration publique
École Polytechnique de Montréal
Emily Carr University of Art and Design

Fanshawe College
First Nations Health Authority
Fleming College

Georgian College
Grant MacEwan University

HEC Montréal
Hospital for Sick Children
Humber College
Huron University College

Indigenous Diabetes Health Circle
INRS
Institut de recherches cliniques de Montréal
Institut de tourisme et d'hôtellerie du Québec
Institut national de la recherche scientifique
Institut national de santé publique du Québec
Institute for Work & Health
IWK Health Centre

John Abbott College
Justice Institute of British Columbia

Keenan Research Centre
King's University College at Western University
Kwantlen Polytechnic University

MacEwan University (Grant MacEwan University)
McGill University
McMaster University
Memorial University of Newfoundland
Métis Nation of Ontario
Mount Royal University
Mount Saint Vincent University
Moyo Health and Community Services

Native Women's Association of Canada
North Island College
North York General Hospital
Northern Ontario School of Medicine
Nova Scotia Health Authority

OCAD University
Ontario Centre of Excellence for Child and Youth Mental Health
Ontario Institute for Cancer Research
Ontario Tech University
Ontario Tech University (University of Ontario Institute of Technology)
Ottawa Heart Institute Research Corporation
Ottawa Hospital Research Institute

Princess Margaret Cancer Centre

Québec à Chicoutimi
Québec à Montréal
Québec à Rimouski
Québec à Trois-Rivières
Queen's University

Royal Alexandra Hospital
Royal Roads University
Ryerson University

TÉLUQ
The University of Calgary
The University of Regina
Thompson Rivers University
Toronto General Research Institute
Trent University
Trillium Health Partners

Vancouver Island University

Western University
Western University (The University of Western Ontario)
Wilfrid Laurier University
Women's College Hospital

York University
Yukon University

Back to main page

Displaying 321 through 330 of 353 results (Download Results)

Show results per page

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial

Liu, Peter P | Ottawa Heart Institute Research Corporation | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – The COVID‑19 Ontario Pregnancy Event (COPE) Network: Assessing the impact of COVID‑19 in pregnancy on maternal, fetal and newborn health

El-Chaar, Darine | Ottawa Hospital Research Institute | Operating Grant | $50,000

CIHR Ontario 2021

Predictors and burden of post-acute COVID‑19 syndrome (long-COVID) with a focus on equity

Sander, Beate H | Toronto General Research Institute | Operating Grant | $499,645

CIHR Ontario 2021

Viral diversity and immune escape variants in vulnerable individuals post-vaccination.

Piccirillo, Ciriaco A | McGill University | Operating Grant | $499,500

CIHR Quebec 2021

Assessing Immunogenicity of Covid-19 Vaccines in Survivors of Hematological and Solid Cancers

Grant, Michael D | Memorial University of Newfoundland | Operating Grant | $379,900

CIHR Newfoundland and Labrador 2021

Parental presence restrictions due to COVID-19: Examining impact and priorities for neonatal care (The PRESENCE Study)

Campbell-Yeo, Marsha L | Dalhousie University | Operating Grant | $193,100

CIHR Nova Scotia 2021

The McMaster Multi-Regional Hospital Coronavirus Registry (COREG): Extending a Rapid Research Platform to Inform the Clinical Management of COVID‑19 ‘long haulers’

Beauchamp, Marla K | McMaster University | Operating Grant | $497,800

CIHR Ontario 2021

COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein

Perrin, David M | University of British Columbia | Operating Grant | $50,000

CIHR British Columbia 2021

COVID-19 Variant Supplement – Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19

Xing, Zhou | McMaster University | Operating Grant | $50,000

CIHR Ontario 2021

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity

Leduc, Richard | Université de Sherbrooke | Operating Grant | $50,000

CIHR Quebec 2021

The Canadian COVID‑19 Funded Research Database

Advanced Keyword Search

Provinces & Territories (12)

Institutions (175)

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

Y

Years (4)

Funding Agencies (3)

Languages (2)

Funding Amount

COVID-19 Variant Supplement – Improving Outcomes in Individuals with COVID‑19 with Renin-Angiotensin System Inhibition: The COVID-RASi Trial

COVID-19 Variant Supplement – The COVID‑19 Ontario Pregnancy Event (COPE) Network: Assessing the impact of COVID‑19 in pregnancy on maternal, fetal and newborn health

Predictors and burden of post-acute COVID‑19 syndrome (long-COVID) with a focus on equity

Viral diversity and immune escape variants in vulnerable individuals post-vaccination.

Assessing Immunogenicity of Covid-19 Vaccines in Survivors of Hematological and Solid Cancers

Parental presence restrictions due to COVID-19: Examining impact and priorities for neonatal care (The PRESENCE Study)

The McMaster Multi-Regional Hospital Coronavirus Registry (COREG): Extending a Rapid Research Platform to Inform the Clinical Management of COVID‑19 ‘long haulers’

COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein

COVID-19 Variant Supplement – Rapid bench-to-human development of safe and effective aerosol vaccine strategies against Covid-19

COVID-19 Variant Supplement – Preventing SARS-CoV-2 infection by targeting human type II transmembrane serine protease activity